January 2, 2025 · Form 4 insider transaction
Berger Dietmar bought 48,975 shares of Gilead Sciences, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.; The restricted stock units have a three year vesting schedule. 33.33% will vest on the anniversary of the date of grant until fully vested.